chr19-7269310-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000208.4(INSR):c.101-1414T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 149,738 control chromosomes in the GnomAD database, including 9,117 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.34   (  9117   hom.,  cov: 27) 
Consequence
 INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.219  
Publications
9 publications found 
Genes affected
 INSR  (HGNC:6091):  (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] 
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.562  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.101-1414T>C | intron_variant | Intron 1 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.101-1414T>C | intron_variant | Intron 1 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.101-1414T>C | intron_variant | Intron 1 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.101-1414T>C | intron_variant | Intron 1 of 20 | XP_011526291.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | c.101-1414T>C | intron_variant | Intron 1 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.101-1414T>C | intron_variant | Intron 1 of 20 | 1 | ENSP00000342838.4 | ||||
| INSR | ENST00000598216.1 | n.76-1414T>C | intron_variant | Intron 1 of 9 | 1 | 
Frequencies
GnomAD3 genomes  0.338  AC: 50497AN: 149618Hom.:  9101  Cov.: 27 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
50497
AN: 
149618
Hom.: 
Cov.: 
27
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.338  AC: 50544AN: 149738Hom.:  9117  Cov.: 27 AF XY:  0.338  AC XY: 24656AN XY: 72944 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
50544
AN: 
149738
Hom.: 
Cov.: 
27
 AF XY: 
AC XY: 
24656
AN XY: 
72944
show subpopulations 
African (AFR) 
 AF: 
AC: 
16917
AN: 
40602
American (AMR) 
 AF: 
AC: 
3481
AN: 
14918
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
802
AN: 
3444
East Asian (EAS) 
 AF: 
AC: 
2939
AN: 
5072
South Asian (SAS) 
 AF: 
AC: 
1720
AN: 
4742
European-Finnish (FIN) 
 AF: 
AC: 
3393
AN: 
10070
Middle Eastern (MID) 
 AF: 
AC: 
95
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
20116
AN: 
67626
Other (OTH) 
 AF: 
AC: 
674
AN: 
2068
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.515 
Heterozygous variant carriers
 0 
 1555 
 3110 
 4666 
 6221 
 7776 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 512 
 1024 
 1536 
 2048 
 2560 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1622
AN: 
3468
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.